Some non-CKD–MBD biomarkers, such as asymmetric dimethylarginine (ADMA), resistin, and C-reactive protein (CRP), were demonstrated to be related to a number of cardiovascular diseases. This evidence concerns the gene RETN and cardiovascular disorder.